170 related articles for article (PubMed ID: 1327071)
1. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
4. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
5. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
6. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
7. Impaired processing of proopiomelanocortin in corticotroph macroadenomas.
Gibson S; Ray DW; Crosby SR; Dornan TL; Jennings AM; Bevan JS; Davis JR; White A
J Clin Endocrinol Metab; 1996 Feb; 81(2):497-502. PubMed ID: 8636257
[TBL] [Abstract][Full Text] [Related]
8. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
[TBL] [Abstract][Full Text] [Related]
9. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states.
Westphal M; Lüdecke DK
Mol Cell Endocrinol; 1984 Sep; 37(2):145-51. PubMed ID: 6092171
[TBL] [Abstract][Full Text] [Related]
10. Monoclonality of corticotroph macroadenomas in Cushing's disease.
Gicquel C; Le Bouc Y; Luton JP; Girard F; Bertagna X
J Clin Endocrinol Metab; 1992 Aug; 75(2):472-5. PubMed ID: 1322426
[TBL] [Abstract][Full Text] [Related]
11. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor.
Miller WL; Johnson LK
J Clin Endocrinol Metab; 1982 Sep; 55(3):441-6. PubMed ID: 6284780
[TBL] [Abstract][Full Text] [Related]
17. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
Suda T
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome due to ectopic proopiomelanocortin gene expression by islet cell carcinoma of the pancreas.
Melmed S; Yamashita S; Kovacs K; Ong J; Rosenblatt S; Braunstein G
Cancer; 1987 Feb; 59(4):772-8. PubMed ID: 3026608
[TBL] [Abstract][Full Text] [Related]
20. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
